Christine M Heske

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 24

Top Topics

Chronic Myeloid Leukemia

Top Venues

Molecular cancer therapeutics

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Victor J Collins, Katelyn R Ludwig, Ariana E Nelson, Soumya Sundara Rajan, Choh Yeung, Ksenia Vulikh, Kristine A Isanogle, Arnulfo Mendoza, Simone Difilippantonio, Baktiar O Karim, Natasha J Caplen, Christine M Heske
Enhancing Standard of Care Chemotherapy Efficacy Using DNA-Dependent Protein Kinase (DNA-PK) Inhibition in Preclinical Models of Ewing Sarcoma. Molecular cancer therapeutics 23 (8) (2024)
Victor J Collins, Katelyn R Ludwig, Ariana E Nelson, Soumya Sundara Rajan, Choh Yeung, Ksenia Vulikh, Kristine A Isanogle, Arnulfo Mendoza, Simone Difilippantonio, Baktiar O Karim, Natasha J Caplen, Christine M Heske
Enhancing Standard of Care Chemotherapy Efficacy Using DNA-Dependent Protein Kinase (DNA-PK) Inhibition in Preclinical Models of Ewing Sarcoma. Molecular cancer therapeutics 23 (8) (2024)
Victor J Collins, Katelyn R Ludwig, Ariana E Nelson, Soumya Sundara Rajan, Choh Yeung, Ksenia Vulikh, Kristine A Isanogle, Arnulfo Mendoza, Simone Difilippantonio, Baktiar O Karim, Natasha J Caplen, Christine M Heske
Enhancing Standard of Care Chemotherapy Efficacy Using DNA-Dependent Protein Kinase (DNA-PK) Inhibition in Preclinical Models of Ewing Sarcoma. Molecular cancer therapeutics 23 (8) (2024)
Victor J Collins, Katelyn R Ludwig, Ariana E Nelson, Soumya Sundara Rajan, Choh Yeung, Ksenia Vulikh, Kristine A Isanogle, Arnulfo Mendoza, Simone Difilippantonio, Baktiar O Karim, Natasha J Caplen, Christine M Heske
Enhancing Standard of Care Chemotherapy Efficacy Using DNA-Dependent Protein Kinase (DNA-PK) Inhibition in Preclinical Models of Ewing Sarcoma. Molecular cancer therapeutics 23 (8) (2024)
Sophia J Zhao, Daniel Prior, Christine M Heske, Juan C Vasquez
Therapeutic Targeting of DNA Repair Pathways in Pediatric Extracranial Solid Tumors: Current State and Implications for Immunotherapy. Cancers 16 (9) (2024)
Victor J Collins, Katelyn R Ludwig, Ariana E Nelson, Soumya Sundara Rajan, Choh Yeung, Ksenia Vulikh, Kristine A Isanogle, Arnulfo Mendoza, Simone Difilippantonio, Baktiar O Karim, Natasha J Caplen, Christine M Heske
Enhancing Standard of Care Chemotherapy Efficacy Using DNA-Dependent Protein Kinase (DNA-PK) Inhibition in Preclinical Models of Ewing Sarcoma. Molecular cancer therapeutics 23 (8) (2024)
Jonathan L Metts, Jamie M Aye, Jacquelyn N Crane, Sara J Israels, Frank Milton Balis, Smita Bhatia, Kira Bona, Bruce Carleton, Roshni Dasgupta, Filemon S Dela Cruz, Katie A Greenzang, Jonathan L Kaufman, Corinne M Linardic, Susan K Parsons, Mark Robertson-Tessi, Erin R Rudzinski, Alice Soragni, Elizabeth Stewart, Brenda J Weigel, Suzanne L Wolden, Aaron R Weiss, Rajkumar Venkatramani, Christine M Heske
Roadmap for the next generation of Children's Oncology Group rhabdomyosarcoma trials. Cancer (2024)
Sophia J Zhao, Daniel Prior, Christine M Heske, Juan C Vasquez
Therapeutic Targeting of DNA Repair Pathways in Pediatric Extracranial Solid Tumors: Current State and Implications for Immunotherapy. Cancers 16 (9) (2024)
Sophia J Zhao, Daniel Prior, Christine M Heske, Juan C Vasquez
Therapeutic Targeting of DNA Repair Pathways in Pediatric Extracranial Solid Tumors: Current State and Implications for Immunotherapy. Cancers 16 (9) (2024)
Jonathan L Metts, Jamie M Aye, Jacquelyn N Crane, Sara J Israels, Frank Milton Balis, Smita Bhatia, Kira Bona, Bruce Carleton, Roshni Dasgupta, Filemon S Dela Cruz, Katie A Greenzang, Jonathan L Kaufman, Corinne M Linardic, Susan K Parsons, Mark Robertson-Tessi, Erin R Rudzinski, Alice Soragni, Elizabeth Stewart, Brenda J Weigel, Suzanne L Wolden, Aaron R Weiss, Rajkumar Venkatramani, Christine M Heske
Roadmap for the next generation of Children's Oncology Group rhabdomyosarcoma trials. Cancer (2024)
Victor J Collins, Katelyn R Ludwig, Ariana E Nelson, Soumya Sundara Rajan, Choh Yeung, Ksenia Vulikh, Kristine A Isanogle, Arnulfo Mendoza, Simone Difilippantonio, Baktiar O Karim, Natasha J Caplen, Christine M Heske
Enhancing Standard of Care Chemotherapy Efficacy Using DNA-Dependent Protein Kinase (DNA-PK) Inhibition in Preclinical Models of Ewing Sarcoma. Molecular cancer therapeutics 23 (8) (2024)
Jonathan L Metts, Jamie M Aye, Jacquelyn N Crane, Sara J Israels, Frank Milton Balis, Smita Bhatia, Kira Bona, Bruce Carleton, Roshni Dasgupta, Filemon S Dela Cruz, Katie A Greenzang, Jonathan L Kaufman, Corinne M Linardic, Susan K Parsons, Mark Robertson-Tessi, Erin R Rudzinski, Alice Soragni, Elizabeth Stewart, Brenda J Weigel, Suzanne L Wolden, Aaron R Weiss, Rajkumar Venkatramani, Christine M Heske
Roadmap for the next generation of Children's Oncology Group rhabdomyosarcoma trials. Cancer (2024)
Jonathan L Metts, Jamie M Aye, Jacquelyn N Crane, Sara J Israels, Frank Milton Balis, Smita Bhatia, Kira Bona, Bruce Carleton, Roshni Dasgupta, Filemon S Dela Cruz, Katie A Greenzang, Jonathan L Kaufman, Corinne M Linardic, Susan K Parsons, Mark Robertson-Tessi, Erin R Rudzinski, Alice Soragni, Elizabeth Stewart, Brenda J Weigel, Suzanne L Wolden, Aaron R Weiss, Rajkumar Venkatramani, Christine M Heske
Roadmap for the next generation of Children's Oncology Group rhabdomyosarcoma trials. Cancer (2024)
Victor J Collins, Katelyn R Ludwig, Ariana E Nelson, Soumya Sundara Rajan, Choh Yeung, Ksenia Vulikh, Kristine A Isanogle, Arnulfo Mendoza, Simone Difilippantonio, Baktiar O Karim, Natasha J Caplen, Christine M Heske
Enhancing standard of care chemotherapy efficacy using DNA-dependent protein kinase (DNA-PK) inhibition in preclinical models of Ewing sarcoma. Molecular cancer therapeutics (2024)
Grace B McKay-Corkum, Victor J Collins, Choh Yeung, Takeshi Ito, Sameer H Issaq, David O Holland, Ksenia Vulikh, Yiping Zhang, Unsun Lee, Haiyan Lei, Arnulfo Mendoza, Jack F Shern, Marielle E Yohe, Kazutoshi Yamamoto, Kelli M Wilson, Jiuping Ji, Baktiar O Karim, Craig J Thomas, Murali C Krishna, Leonard M Neckers, Christine M Heske
Inhibition of NAD+-dependent metabolic processes induces cellular necrosis and tumor regression in rhabdomyosarcoma models. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Senna R Munnikhuysen, Princess A Ekpo, Wei Xue, Zhengya Gao, Philip J Lupo, Rajkumar Venkatramani, Christine M Heske
Impact of race and ethnicity on presentation and outcomes of patients treated on rhabdomyosarcoma clinical trials: A report from the Children's Oncology Group. Cancer medicine (2023)
Senna R Munnikhuysen, Princess A Ekpo, Wei Xue, Zhengya Gao, Philip J Lupo, Rajkumar Venkatramani, Christine M Heske
Impact of race and ethnicity on presentation and outcomes of patients treated on rhabdomyosarcoma clinical trials: A report from the Children's Oncology Group. Cancer medicine (2023)
Srivandana Akshintala, R Taylor Sundby, Donna B Bernstein, John W Glod, Rosandra N Kaplan, Marielle E Yohe, Andrea M Gross, Joanne Derdak, Haiyan Lei, Alexander Pan, Eva Dombi, Isabel Palacio-Yance, Kailey R Herrera, Markku M Miettinen, Helen X Chen, Seth M Steinberg, Lee J Helman, Leo Mascarenhas, Brigitte C Widemann, Fariba Navid, Jack F Shern, Christine M Heske
Phase I trial of ganitumab plus dasatinib to cotarget the insulin-like growth factor 1 receptor and Src family kinase YES in rhabdomyosarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Senna R Munnikhuysen, Princess A Ekpo, Wei Xue, Zhengya Gao, Philip J Lupo, Rajkumar Venkatramani, Christine M Heske
Impact of race and ethnicity on presentation and outcomes of patients treated on rhabdomyosarcoma clinical trials: A report from the Children's Oncology Group. Cancer medicine (2023)
Senna R Munnikhuysen, Princess A Ekpo, Wei Xue, Zhengya Gao, Philip J Lupo, Rajkumar Venkatramani, Christine M Heske
Impact of race and ethnicity on presentation and outcomes of patients treated on rhabdomyosarcoma clinical trials: A report from the Children's Oncology Group. Cancer medicine (2023)
Christine M Heske, Leo Mascarenhas
Relapsed Rhabdomyosarcoma. Journal of clinical medicine 10 (4) (2021)
Holly L Pacenta, Wendy Allen-Rhoades, David Langenau, Peter J Houghton, Charles Keller, Christine M Heske, Michael D Deel, Corinne M Linardic, Jack F Shern, Elizabeth Stewart, Brian Turpin, Douglas J Harrison, Javed Khan, Leo Mascarenhas, Stephen X Skapek, William H Meyer, Douglas S Hawkins, Eleanor Y Chen, James F Amatruda, Pooja Hingorani, Theodore W Laetsch
Prioritization of Novel Agents for Patients with Rhabdomyosarcoma: A Report from the Children's Oncology Group (COG) New Agents for Rhabdomyosarcoma Task Force. Journal of clinical medicine 10 (7) (2021)
Christine M Heske, Yueh-Yun Chi, Rajkumar Venkatramani, Minjie Li, Michael A Arnold, Roshni Dasgupta, Susan M Hiniker, Douglas S Hawkins, Leo Mascarenhas
Survival outcomes of patients with localized FOXO1 fusion-positive rhabdomyosarcoma treated on recent clinical trials: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Cancer 127 (6) (2020)
Anna E Gibson, Choh Yeung, Sameer H Issaq, Victor J Collins, Michael Gouzoulis, Yiping Zhang, Jiuping Ji, Arnulfo Mendoza, Christine M Heske
Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) with OT-82 induces DNA damage, cell death, and suppression of tumor growth in preclinical models of Ewing sarcoma. Oncogenesis 9 (9) (2020)